Diagnostic Accuracy of Xpert MTB/RIF Ultra in suspected TB with two sputum smear negative Acid-fast Bacteria
Main Article Content
Abstract
TB Cases with two negative sputum samples accounted for about 23% of all TB. This number tends to increase gradually due to the early detection of TB and effective treatment. The Xpert MBT/RIF Ultra test is the 4th generation of the Xpert MTB test, with higher sensitivity. We describe the clinical and laboratory characteristics and determine the value of Xpert MTB/RIF Ultra sputum test in the diagnosis of pulmonary tuberculosis in patients with two negative AFB sputum samples. A cross-sectional descriptive study was performed on 201 suspected TB patients with two negative AFB sputum samples. The study results showed that the proportion of men is 67.7%, the age group from 40 to 64 years old accounted for the highest rate 51.2%, the self-employed accounted for 39.8%. The main reason for admission was cough, accounting for 60.2%. 49.3% of patients had fever, mainly mild fever accounting for 77.8%. On CT chest scan, nodular lesions had the highest rate of 62,2%, ground glass opacity lesions on thoracic CT had MGIT (+) 2.27 times higher with statistical significance with p = 0.041. The sensitivity of Xpert MTB/RIF Ultra compared with MGIT sputum is Se 83.3% (50/60), specificity is Sp 95,7% (135/141), PPV positive predictive value is 89.3 % (50/56), the negative predictive value is NPV 93.1% (135/145). The sensitivity of the trace Xpert MTB/RIF Ultra to sputum MGIT is 30% (3/10), the specificity is 91.9% (124/135), the positive predictive value is 21.4% (3). /14), the negative predictive value is 94.7% (124/131). Xpert MTB/RIF Ultra Sputum is highly sensitive and specific in TB sputum smear negative diagnosis
Article Details
Keywords
Presumative TB, AFB (-), Gen Xpert Ultra, pulmonary tuberculosis, MGIT culture.
References
2. Nguyễn Kim Cương, Nguyễn Viết Nhung. Đặc điểm lâm sàng, cận lâm sàng, giá trị Gene Xpert MTB/RIF trong chẩn đoán lao phổi AFB(-) ở người nhiễm HIV, Tạp chí Y học dự phòng, tập XXV, số 10(170) 2015, 87-93.
3. Zhang X, Andersen AB, Lillebaek T, et al. Effect of sex, age, and race on the clinical presentation of tuberculosis: a 15-year population-based study. The American journal of tropical medicine and hygiene. Aug 2011;85(2):285-90. doi:10.4269/ajtmh.2011.10-0630.
4. Linguissi LS, Vouvoungui CJ, Poulain P, Essassa GB, Kwedi S, Ntoumi F. Diagnosis of smear-negative pulmonary tuberculosis based on clinical signs in the Republic of Congo. BMC Res Notes. Dec 18 2015;8:804. doi:10.1186/s13104-015-1774-8.
5. Planning for country transition to Xpert®MTB/RIF Ultra cartridges. www.stoptb.org/wg/gli/assets/documents/gli_ultra.pdf. Accessed October 2, 2020.
6. Chakravorty S, Simmons AM, Rowneki M, et al. The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing. mBio. Aug 29 2017; 8(4)doi:10.1128/mBio.00812-17.
7. Roy P, Anand A. Serious discordance between MTBC trace positivity by Xpert MTB/RIF ultra and follow up culture. International Journal of Research in Medical Sciences; Vol 8, No 8 (2020): August 2020DO - 1018203/2320-6012ijrms20203482. 07/24/ 2020.
8. Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. Jan 2018; 18(1):76-84. doi:10.1016/S1473-3099(17)30691-6.